Our lawyers are currently investigating Belviq lawsuits. Belviq was approved by the FDA in 2012 based on the requirement that the manufacturer Eisai complete a double-blind, placebo-controlled clinical trial. The test included 12,000 people over five years.
FDA Belviq Recall
After the FDA received the results of the study and analyzed the information, it determined that more patients taking Belviq were diagnosed with cancer compared to patients taking a placebo.
Here is a link to the FDA recall notice: https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market
“We are taking this action because we believe that the risks of lorcaserin outweigh its benefits based on our completed review of results from a randomized clinical trial assessing safety.”
What types of cancer is Belviq causing?
Although the FDA found that Belviq caused a variety of cancers, the agency specifically stated that they found pancreatic, colorectal and lung cancer as being more prevalent.
Talk With a Product Liability Lawyer – Free Belviq Lawsuit Review
If you or a loved one has been diagnosed with cancer after taking Belviq or Belviq XR, you should speak with the lawyers at Johnson // Becker.
We offer a Free Case Evaluation. Please contact us using the form below or by calling us at (800) 279-6386. We would be honored to speak with you and respond promptly to every inquiry we receive.